Limin Chemical has disclosed a restructuring decision taken earlier this month to acquire Veyong (Hebei Veyong Bio-Chemical Co), the pesticide businesses of ENN and a wholly-owned subsidiary of ENN Group. The purpose of the intended acquisition is for Limin Chemical to maintain its leading position in the agrochemical industry and to make improvements to its industrial deployment.

Limin Chemical says that before this transaction, its main products were predominantly EBDC fungicides, while the Veyong pesticide portfolio is based upon insecticides, such as emamectin benzoate and abamectin, backed up by the advanced continuous gas phase synthesis process in glufosinate production. Furthermore, Veyong’s veterinary business, which covers tiamulin, ivermectin and eprinomectin, will make up for the gap in the veterinary drug business of Limin Chemical. The merger will therefore be complementary with respect to the optimization of product structure and development of technical processes.